Spero Therapeutics (SPRO) Share-based Compensation Growth (1y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 206.26% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -69.95% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 0.18% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 0.66% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 23.70% |
| 10 | Spero Therapeutics | 162.39 Mn | 106.26 Mn | - | -28.41% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -28.41% |
| Dec 31, 2025 | -33.00% |
| Sep 30, 2025 | -51.35% |
| Jun 30, 2025 | -66.21% |
| Mar 31, 2025 | -23.08% |
| Dec 31, 2024 | -24.74% |
| Sep 30, 2024 | 12.89% |
| Jun 30, 2024 | 13.79% |
| Mar 31, 2024 | -6.77% |
| Dec 31, 2023 | -20.02% |
| Sep 30, 2023 | -9.40% |
| Jun 30, 2023 | 41.00% |
| Mar 31, 2023 | -32.25% |
| Dec 31, 2022 | -14.72% |
| Sep 30, 2022 | -9.61% |
| Jun 30, 2022 | -39.11% |
| Mar 31, 2022 | 59.43% |
| Dec 31, 2021 | 114.51% |
| Sep 30, 2021 | 94.33% |
| Jun 30, 2021 | 78.17% |
| Mar 31, 2021 | 80.99% |
| Dec 31, 2020 | 46.93% |
| Sep 30, 2020 | 22.22% |
| Jun 30, 2020 | 30.12% |
| Mar 31, 2020 | 18.97% |
| Dec 31, 2019 | 20.81% |
| Sep 30, 2019 | 39.15% |
| Jun 30, 2019 | 41.15% |
| Mar 31, 2019 | 51.95% |
| Dec 31, 2018 | 106.17% |
| Sep 30, 2018 | -24.27% |
| Jun 30, 2018 | 983.61% |
| Mar 31, 2018 | 890.32% |
| Dec 31, 2017 | 492.06% |
| Sep 30, 2017 | 1,451.67% |